|Bid||30.81 x 2200|
|Ask||30.82 x 1200|
|Day's Range||29.36 - 30.91|
|52 Week Range||17.51 - 62.48|
|Beta (5Y Monthly)||1.32|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jan 12, 2021 - Jan 18, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Feb 19, 2020|
|1y Target Est||38.78|
New, daily, U.S. coronavirus cases hit 80,000 on Thursday, with Regeneron posting positive results from its antibody cocktail trial, Moderna saying it is ‘actively preparing’ for a global launch of it vaccine, and Gilead announcing it sold $873 million dollars worth of its antiviral treatment. Yahoo Finance’s Anjalee Khemlani joins The Final Round to discuss the latest on the coronavirus.
Yahoo Finance’s Kristin Myers and ETF Trends CEO Tom Lydon discuss how the coronavirus is weighing on the airline industry.
Allegiant's (ALGT) third-quarter results are hurt by low passenger revenue. Nevertheless, reduced fuel costs are tailwinds.